ABSTRACT
The lipidaemic profile has been evaluated in a series of 603 healthy children aged 13-14, within a programme for the prevention of atherosclerotic disease commenced in November 1980 at Health Unit 66 of the Region of Piedmont. Hyperlipaemia is among the environmental risk factors for ATS and more than any of the others it regards paediatric age and can be acted upon. Analysis of the results shows that 172 subjects (28.5%) present pathological values of one or more of the following laboratory examinations: total cholesterol, cholesterol-HDL, cholesterol-LDL, triglycerides, apolipoprotein A1 and apolipoprotein B. In 17 children (2.82%), changes in lipidaemic balance were so marked that they prefigured a high risk of cardiovascular disease at adult age. All dyslipidaemic subjects were recommended a suitable, balanced antiatherogenous diet and later control of the altered examinations. Courses of dietary education in secondary schools were also instituted so as to make all students and their parents, teachers and the population at large aware of the problem.
Subject(s)
Apolipoproteins/blood , Arteriosclerosis/prevention & control , Hyperlipidemias/epidemiology , Lipids/blood , Adolescent , Female , Humans , Italy/epidemiology , Male , Risk FactorsSubject(s)
Alkaline Phosphatase/blood , Infant, Newborn , Isoenzymes/blood , Humans , Reference ValuesSubject(s)
Infant, Newborn, Diseases , Tuberculosis, Pulmonary/congenital , Female , Humans , Infant, NewbornSubject(s)
Dehydration/complications , Diabetic Coma , Hyperglycemic Hyperosmolar Nonketotic Coma , Infant Nutrition Disorders/complications , Infant, Newborn, Diseases , Diabetic Coma/etiology , Female , Humans , Hyperglycemic Hyperosmolar Nonketotic Coma/etiology , Infant, Newborn , Infant, Newborn, Diseases/etiologyABSTRACT
The survival of children with Wilms' tumour is evaluated in 11 males and 12 females treated between 1967 and 1975 in the light of the clinical stage, age at diagnosis, and sex. The subjects were aged from 4 months to 6 years. Six were in stage I, 4 in stage II, 4 in stage III, 7 in stage IV, and 2 in stage V. Survival in stage I was 100% at 36 months and gradually decreased with the stage. Patients aged less than 2 years presented a survival of 50% two years after diagnosis, compared to 24% in those over 2 years old. Sex appears to be irrelevant to prognosis.